Mrv1909 02112022392D 17 20 0 0 0 0 999 V2000 1.7840 0.2269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2271 -0.6187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4021 0.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4021 -0.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1653 0.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0622 0.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2990 -0.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2990 0.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0622 -0.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2990 -1.6705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7428 -0.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2990 1.6706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7428 -1.6705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1653 1.6706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4021 2.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0622 -2.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7840 0.9074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 5 1 1 0 0 0 0 4 2 2 0 0 0 0 4 3 1 0 0 0 0 5 3 2 0 0 0 0 8 3 1 0 0 0 0 7 4 1 0 0 0 0 14 5 1 0 0 0 0 8 6 1 0 0 0 0 9 6 1 0 0 0 0 17 6 2 0 0 0 0 9 7 2 0 0 0 0 10 7 1 0 0 0 0 12 8 2 0 0 0 0 11 9 1 0 0 0 0 16 10 2 0 0 0 0 13 11 2 0 0 0 0 15 12 1 0 0 0 0 16 13 1 0 0 0 0 15 14 2 0 0 0 0 M END > DB01782 > drugbank > O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2 > InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16) > ACPOUJIDANTYHO-UHFFFAOYSA-N > C14H8N2O > 220.2261 > 220.063662888 > 2 > 25 > 0.9004744517689542 > 22.715243475078836 > 1 > 1 > 0 > 1 > 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one > 2.76 > 2.8154905973333335 > -3.07 > 0 > 0 > 4 > 0 > 10.020758357407562 > 0.9565368183101194 > 45.75 > 65.35480000000001 > 0 > 1 > 1.86e-01 g/l > 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one > 0 > DB01782 > EXPT00232 > experimental > Pyrazolanthrone > 1,9-Pyrazoloanthrone; Anthra(1,9-cd)pyrazol-6(2H)-one; Pyrazoleanthrone $$$$